Home » Market News » DirectorsTalk Highlights » Prostate cancer warning: Five symptoms you may be ignoring
Avacta Group Plc

Prostate cancer warning: Five symptoms you may be ignoring

Prostate cancer is the most common type of cancer to be diagnosed in men, in the UK. The diseases affects the prostate which is a small gland that is found in the pelvis in men. It’s not always easy to know if you’re at risk of prostate cancer, as the symptoms tend to develop very slowly over a long period of time. You could be at risk of prostate cancer if you suddenly find yourself needing to pass urine more often than normal, it’s been revealed.

Avacta Group Plc (LON:AVCT) principal focus is on its proprietary Affimer® technology which is a novel engineered alternative to antibodies that has wide application in Life Sciences for diagnostics, therapeutics and general research and development.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.